Comments
Applied Genetic Technologies Corporation (AGTC) reported positive 3-month interim data from its ongoing phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP).
https://bit.ly/3G3n7n1
Technological advances have significantly affected how we approach ophthalmic surgery, particularly with the advent of 3D visualization systems with heads-up displays. Here, we discuss the benefits of this relatively new technologyâand what to watch out for when using it in the OR.
https://bit.ly/3wjhFsW
For Makoto Inoue, MD, efficiency is key when it comes to removing the vitreous. Alconâs HyperVit dual blade vitrectomy probe nearly doubles the efficiency of traditional 10K bevel cutters. Hear more about his experiences with this new tool.
https://bit.ly/3wfHkT8 #ophthalmology #sponsored #thisisretina
A Primer on Diagnostic Ophthalmic Ultrasound
Continued improvements to this imaging modality have made it an indispensable tool for the retina specialist.
https://bit.ly/3Lf57XS
Hyperglycemia in diabetes can stimulate increased vascular endothelial growth factor (VEGF), leading to fluid accumulation in the extravascular space in diabetic macular edema (DME). Watch to learn about #DME-related vision loss.
https://bit.ly/DME-MOD
#RetinaWorldCongress #Sponsored by Novartis Pharmaceuticals Corporation and intended for US audiences only
With the significant changes to E/M documentation guidelines and value in 2021, now is a good time to rethink some of your coding patterns for various scenarios. Below are some helpful tips to help you decide how to properly code patient visits.
https://bit.ly/3FLNX2F
In this article, we discuss tips and tricks of endoscopy-assisted vitrectomy used in combination with a 3D heads-up display system (Ngenuity, Alcon).
https://bit.ly/3w6TWfk
Herein we describe a child with bilateral RB who presented at the initial ophthalmic diagnosis with a suprasellar mass.
https://bit.ly/3M8QSVN
Glenn Jaffe, MD will present a post hoc analysis of the GATHER1 Trial including the evaluation of GA lesion growth by minimum distance to the fovea center at the annual Retina World Congress on May 13th at 5:30pm EST. We hope youâll join us!
The PIVOT trial provided the first randomized longitudinal prospective imaging dataset, which enabled us to answer questions not only about PnR versus PPV, but also about RRD repair in general. Based on post-hoc studies and analyses that emerged from the PIVOT trial, here are the top 10 lessons learned in the management of RRD.
https://bit.ly/3Ftq3ck
Join Evolve Medical Education LLC for a live virtual symposium on neovascular age-related macular degeneration, featuring Drs. Nancy Holekamp, W. Lloyd Clark, and John Kitchens! Register today:
https://bit.ly/37iDu2a
No-fee #CME #Retina Series: "Modernizing Medical Retina," with Drs. Christina Weng (chair); Sophie Bakri; Peter Campochiaro; Diana Do; David Eichenbaum; Basil Williams Jr.; and Glenn Yiu. View here:
https://bit.ly/3InjKa8
Evolve Medical Education LLC